A British trial of the AstraZeneca COVID-19 vaccine involving children has been paused over fears of a possible link to blood clots. Oxford University, who helped develop the vaccine, said in a statement: “Whilst there are no safety concerns in the paediatric clinical trial, we await additional information from the MHRA (UK regulator) on its… Read More: AstraZeneca pause UK vaccine trial in children »
Victoria has taken delivery of its first batch of AstraZeneca COVID-19 vaccines, with the rollout of the 50,800 doses to start early next week. It comes as the state on Friday celebrated a week-long run of “doughnut days”, with no locally-acquired coronavirus cases. The Health Department said the AstraZeneca doses had started arriving at Victoria’s… Read More: Vic has first batch of AstraZeneca vaccine »
AstraZeneca made waves last week when it signed a massive $ 750 million deal to ramp production of a University of Oxford COVID-19 vaccine up to 2 billion doses per year. Now, as part of a Trump administration effort to get shots into U.S. hands as soon as possible, AstraZeneca has agreed to another major… Read More: AstraZeneca, Emergent BioSolutions sign $87M deal to produce U.S. supply… »
The year may be winding down, but AstraZeneca and Merck’s Lynparza sure isn’t. It picked up a blockbuster new approval late Wednesday and followed up the act by posting positive phase 3 data Thursday morning. U.S. regulators green-lighted the fast-growing PARP inhibitor in BRCA-mutated ovarian cancer patients who’ve responded partially or completely to an initial… Read More: AstraZeneca, Merck's Lynparza plows ahead in ovarian cancer with $1B-plus… »